Pfizer Inc has pledged to deliver critical new medicines more quickly in low-income nations, but its first such vaccine effort faces hurdles likely to delay distribution in poorer countries by several years, global health officials told Reuters.
LONDON (Reuters) - Pfizer Inc has pledged to deliver critical new medicines more quickly in low-income nations, but its first such vaccine effort faces hurdles likely to delay distribution in poorer countries by several years, global health officials told Reuters. Pfizer made a commitment on more equitable access last year, following criticism that it prioritized wealthy nations for doses of its COVID-19 shot early in the pandemic. The company says it wants to shorten a timeline in which poorer countries often get vaccines many years after they are available elsewhere. The drugmaker received a $28 million grant from the Bill and Melinda Gates Foundation in September to support the launch of the respiratory syncytial virus vaccine in poorer countries, where RSV - a common cold-like virus - is much more likely to be lethal for very young children. | 06:17am
By Jennifer Rigby and Maggie Fick LONDON (Reuters) - Pfizer Inc has pledged to deliver critical new medicines more quickly in low-income nations, but .
By Karen Guzman New grants from the Bill & Melinda Gates Foundation (BMGF) are fueling the expansion of a Yale School of Management faculty-led initiative to promote mask-wearing and rural vaccine delivery in the developing world. The BMGF has donated $3 million to the NORM project, which last year established a successful formula for mask-wearing implementation in Bangladesh,